BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 56280)

  • 21. Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera.
    Brochier J; Abou-Hamed YA; Gueho JP; Revillard JP
    Immunology; 1976 Nov; 31(5):749-58. PubMed ID: 1086826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [T and B lymphocytes in peripheral blood of splenectomized subjects].
    Pluzańska A; Mazurowa A; Robak T
    Acta Haematol Pol; 1976; 7(1):13-21. PubMed ID: 1082705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocytes in patients with variable immunodeficiency and panhypogammaglobulinemia. Evaluation of B and T cell surface markers and a proposed classification.
    Dickler HB; Adkinson NF; Fisher RI; Terry WD
    J Clin Invest; 1974 Mar; 53(3):834-40. PubMed ID: 4544229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
    Chisari FV; Routenberg JA; Edgington TS
    J Clin Invest; 1976 May; 57(5):1227-38. PubMed ID: 1083396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin D-bearing lymphocytes in primary immunodeficiencies.
    Preud'Homme JL; Clauvel JP; Seligmann M
    J Immunol; 1975 Jan; 114(1 Pt 2):481-5. PubMed ID: 1090663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human severe combined immunodeficiency disease: phenotypic and functional characteristics of peripheral B lymphocytes.
    Gougeon ML; Drean G; Le Deist F; Dousseau M; Fevrier M; Diu A; Theze J; Griscelli C; Fischer A
    J Immunol; 1990 Nov; 145(9):2873-9. PubMed ID: 2212666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in the proportion of T and B lymphocytes in human malignant neoplasia in relation to the clinical stage.
    Babusíková O; L' Novotná ; Korec S; Schneková K; Turková D; Havránková M; Plentová K
    Neoplasma; 1975; 22(4):413-21. PubMed ID: 1081657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the failure of IgA specific T helper activity in a patient with immunodeficiency with hyper IgM.
    Mitsuya H; Tomino S; Hisamitsu S; Kishimoto S
    J Clin Lab Immunol; 1979 Nov; 2(4):337-42. PubMed ID: 317110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation capacity of cultured B lymphocytes from immunodeficient patients.
    Wu LY; Lawton AR; Cooper MD
    J Clin Invest; 1973 Dec; 52(12):3180-9. PubMed ID: 4543023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B lymphocytes, T lymphocytes and phytohaemagglutinin responsiveness in atopic dermatitis.
    Andersen E; Hjorth N
    Acta Derm Venereol; 1975; 55(5):345-9. PubMed ID: 52969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro studies of axillary lymph node cells in patients with breast cancer.
    Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
    J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of thymosin-responsive peripheral blood null cells.
    Kaplan J
    Cancer Treat Rep; 1978 Nov; 62(11):1757-61. PubMed ID: 310342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe combined immunodeficiency with B lymphocytes and with normal MLC response.
    Seligmann M; Griscelli C; Preud'homme JL; Sasportes M; Herzog C; Brouet JC
    Birth Defects Orig Artic Ser; 1975; 11(1):154-7. PubMed ID: 50093
    [No Abstract]   [Full Text] [Related]  

  • 37. T and B lymphocyte rosettes in bronchial asthma.
    Ghazanshahi S; Townley R; Chaperone E; Villacorte G
    Ann Allergy; 1976 May; 36(5):324-9. PubMed ID: 1084715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T and B lymphocytes in porcine blood.
    Shimizu M; Pan IC; Hess WR
    Am J Vet Res; 1976 Mar; 37(3):309-17. PubMed ID: 769612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte.
    Bird AG; Hammarström L; Smith CI; Britton S
    Clin Exp Immunol; 1981 Jan; 43(1):165-73. PubMed ID: 6454516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects.
    Lindsten T; Seeley JK; Ballow M; Sakamoto K; St Onge S; Yetz J; Aman P; Purtilo DT
    J Immunol; 1982 Dec; 129(6):2536-40. PubMed ID: 6292291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.